Agilon Health, Inc. (AGL) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Agilon Health, Inc. (AGL) Earnings Overview
As of June 23, 2026, Agilon Health, Inc. (AGL) reported trailing twelve-month net income of -$373M, reflecting -55.6% year-over-year growth. The company earned $-22.42 per diluted share over the past four quarters, with a net profit margin of -6.8%.
Looking at the long-term picture, AGL's historical earnings data spans multiple years. The company achieved its highest annual net income of -$60M in fiscal 2020.
Agilon Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CNC (-$6.44B net income, -3.4% margin), HUM ($1.13B net income, 0.9% margin), CVS ($2.93B net income, 0.4% margin), AGL has room to improve margins relative to the peer group. Compare AGL vs CNC →
AGL Earnings vs Peers
Earnings metrics vs comparable public companies
AGL Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$405M | -55.8% | -$421M | $-24.50 | -6.8% | -7.1% |
| 2024 | -$260M | +0.9% | -$292M | $-15.75 | -4.3% | -4.8% |
| 2023 | -$263M | -146.4% | -$232M | $-16.00 | -6.1% | -5.4% |
| 2022 | -$107M | +73.8% | -$105M | $-6.50 | -4.5% | -4.4% |
| 2021 | -$406M | -576.9% | -$372M | $-27.25 | -26.7% | -24.5% |
| 2020 | -$60M | +78.7% | -$57M | $-4.00 | -4.9% | -4.7% |
| 2019 | -$283M | - | -$107M | $-18.50 | -35.6% | -13.4% |
Download Data
Export AGL earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AGL — Frequently Asked Questions
Quick answers to the most common questions about buying AGL stock.
What is AGL earnings per share (EPS)?
AGL trailing twelve-month (TTM) diluted EPS is $-22.42, reflecting -55.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Agilon Health, Inc.'s net income?
Agilon Health, Inc. (AGL) trailing twelve-month net income is $-373M as of 2025. Earnings declined -55.6% year-over-year.
Is AGL profitable?
AGL is not currently profitable on a TTM basis, reporting a net loss of $-373M. Net margin is -6.8%. Investors should monitor for a return to profitability.
What is AGL's earnings growth rate?
AGL compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are AGL's profit margins?
Agilon Health, Inc. net profit margin is -6.8%, operating margin is -7.1%, and gross margin is -3.2%. Below-average margins reflect competitive or cost pressures. Return on Equity is -135.6%.
Is AGL growing earnings?
AGL earnings are declining — EPS fell -55.6% year-over-year. TTM net income dropped to $-373M. This contrasts with the 5-year CAGR of N/A.
What was AGL's best earnings year?
Agilon Health, Inc.'s highest annual net income on record is $-60M, achieved in fiscal year 2020. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were AGL's earnings last quarter?
AGL's most recent reported quarter was Q1 2026. Net income was $30M with diluted EPS of $1.80. For a full breakdown of all quarters, see the quarterly earnings table on this page.